We hereby submit the Intimation of Closure of Trading Window for insiders of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Speciality Medicines Limited (BSE: 544738) has informed the stock exchange that the trading window for insiders dealing in the company's equity shares will be closed from April 1, 2026, until 48 hours after the declaration and publication of the audited standalone financial results for the half year and full year ended March 31, 2026. The closure is being done in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct. The intimation was signed by Parthkumar Goyani, Chairman and Managing Director. This is a routine compliance step taken before announcing annual and half-yearly results.
No direct impact on shareholders or the stock price. This is a standard regulatory disclosure ahead of financial results, which signals that the audited FY26 results are expected to be released soon and insiders are restricted from trading during this sensitive period.